Biopharma Global

learn more at http://www.biopharmaglobal.com. biopharma global, a non-profit-operating corporation based in the washington d.c. metro area, offers fda & ema regulatory affairs and a complete suite of professional services to address the needs of emerging and growing biotech companies globally dedicated to rare disease research. we are specialists consulting for fda & ema orphan drug development and designations for rare diseases. • our team • our team is led by our chief science officer dr. sandi heibel and active board member dr. marlene haffner. no other firm can provide our level of expertise. as a whole, our team possesses comprehensive knowledge of drug development research for rare diseases, as well as extensive experience with regulatory strategy, scientific writing, regulatory submissions and project management. • our success rate • overall, our regulatory affairs team collectively has a successful track record of having written more than 100 orphan drug submissions with a firs